Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.3B | 2.5B | 2.2B | 2.2B |
Cost of revenue | 2.2B | 2.3B | 2.1B | 2.1B |
Gross profit | 142M | 223M | 137M | 129M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 104M | 109M | 105M | 99M |
Other operating expenses | — | — | — | — |
Operating income | 38M | 114M | 32M | 30M |
Non operating interest income | ||||
Income | 18M | 16M | 16M | 17M |
Expense | 10M | 22M | 21M | 17M |
Other income expense | -6M | 28M | 14M | 16M |
Pretax income | 40M | 136M | 41M | 46M |
Tax provision | 8M | -20M | 190M | -15M |
Net income | 32M | 156M | -149M | 61M |
Basic EPS | 33.0 | — | -153.4 | 62.8 |
Diluted EPS | 33.0 | — | -153.4 | 62.8 |
Basic average shares | 1.1M | — | 1.1M | 1.1M |
Diluted average shares | 1.1M | — | 1.1M | 1.1M |
EBITDA | 147M | 252M | 138M | 142M |
Net income from continuing op. | 32M | 156M | -149M | 61M |
Minority interests | 0 | -2M | 0 | 0 |
Preferred stock dividends | — | — | — | — |